An interphase model for effective elastic properties of concrete composites
Journal of Micromechanics and Molecular Physics · 2016
DOI: 10.1142/s2424913016500053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Micromechanics and Molecular Physics, 2016. Verfasst von Chunxiang Shi und 3 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
In this work, the Eshelby tensor of a finite spherical domain is employed to construct an interphase model to evaluate elastic properties of concrete composites. Explicit formulations of the interphase model via multi-inclusion method for a class of concrete composites are derived. The theoretical estimate based on an improved Hashin–Shtrikman bounds for the Young’s modulus of two-phase concrete composite material are used as a comparison result in the analysis, and the influence of the interfacial transition zone (ITZ) on elastic properties of three-phase concrete composite is studied. Moreover, the homogenization results predicted by the proposed interphase model are compared with the published experimental data. Results obtained in this work show that the proposed interphase model can provide a very accurate estimate of the effective elastic properties of complex concrete composite materials.
Zitieren
APA
Shi, C., Tu, Q., Fan, H., & Li, S. (2016). An interphase model for effective elastic properties of concrete composites. Journal of Micromechanics and Molecular Physics. https://doi.org/10.1142/s2424913016500053
Vancouver
Shi C, Tu Q, Fan H, Li S. An interphase model for effective elastic properties of concrete composites. Journal of Micromechanics and Molecular Physics. 2016. doi:10.1142/s2424913016500053
BibTeX
@article{Shi2016,
author = {Shi, Chunxiang and Tu, Qingsong and Fan, Houfu and Li, Shaofan},
title = {An interphase model for effective elastic properties of concrete composites},
journal = {Journal of Micromechanics and Molecular Physics},
year = {2016},
doi = {10.1142/s2424913016500053}
}
EUVIMED